Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

Get Premium

Register

Sign In

EUR/USD

1.2276

-0.0006

-0.05%

GBP/USD

1.3909

-0.0002

-0.01%

USD/JPY

107.34

-0.2285

-0.21%

USD/CHF

0.9392

0.0005

0.05%

EUR/GBP

0.8826

-0.0004

-0.04%

USD/CAD

1.2693

-0.0005

-0.04%

NZD/USD

0.7317

0.0000

0.00%

EUR/JPY

131.77

-0.3520

-0.27%

EUR/CHF

1.1529

0.0001

0.01%

ImmunoCellular Therapeutics Ltd.

AMEX: IMUCHealthcare / Biotechnology / USA
0.25+0.01+4.17%Vol 1 243 6821Y Perf -90.77%
Feb 21st, 2018 15:59
BID0.24 ASK0.26
Open0.25 Previous Close0.25
Pre-Market- After-Trading-
 - -%  - -%
Target Price
5.00 
Analyst Rating
Hold 3.00
Potencial %
1 900.00 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)9 
Earnings Rating
Buy
Price Range Ratio 52wk %
6.16 
Earnings Date
8th Mar 2018

Today's Price Range

0.230.26

 

52wk Range

0.033.60

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
-13.79%
3 Months
-26.47%
6 Months
-24.24%
1 Year
-90.77%
3 Years
-55.04%
5 Years
-89.75%
Last Quotes
Name / TickerPriceChg.Chg.%
IMUC0.250.01004.17
AAPL171.07-0.7800-0.45
GOOG1 111.348.88000.81
MSFT91.49-1.2300-1.33
XOM74.89-0.8600-1.14
WFC59.73-0.2200-0.37
JNJ129.91-0.9600-0.73
FB177.911.90001.08
GE14.49-0.2500-1.70
JPM115.190.48000.42
...

TickerPriceChg.%52 Week High
AAP114.008.21161.99
MAT17.023.3426.12
EXPD63.993.3367.54
MOS27.462.6233.59
PSA190.752.38232.21
VRSK99.232.26102.00
RHI57.572.2260.59
UTX129.262.21139.24
DLPH50.042.1960.39
AAL52.802.0959.08
SIG50.071.9577.94
CF42.631.9443.98
GPS32.221.9335.68
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 0.80
Current Ratio 0.90
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -14.50
Leverage Ratio -7.70
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-
EBITDA Margin-
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 7.56
PS Ratios -
Price to Cash Flow -
Price to Free Cash Flow -0.70
Cash Flow Per Share -2.37
Price to Tangible Book-16.36
Book Value per Share-0.01
Enterprise Value (in ths.)2 558
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-72.24
ROE last 12 Months -385.10
Return on Assets (5Y Avg) -90.68
ROA last 12 Months -149.26
Return on Capital (5Y Avg) -85.67
ROC last 12 Months -379.69
Return on invested Capital Q -162.66
Return on invested Capital Y-149.35
Assets Turnover0.00
Receivables Turnover-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)0
Revenue per Share 0.00
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q03 2016-2.00-1.6020.00
Q02 2016-2.80-2.4014.29
Q01 2016-2.80-2.800.00
Q04 2015-1.60-2.40-50.00
Q03 2015-1.60-1.600.00
Q02 2015-0.03-0.030.00
Q01 2015-0.02-0.04-100.00
Q04 2014-0.05-0.0420.00
Earnings Per EndEstimateRevision %Trend
12/2016 QR-1.7626.67Positive
12/2016 FY-6.7011.84Positive
12/2017 FY-8.572.61Positive
----
Next Report Date8th Mar 2018
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume1 243 682
Shares Outstanding (in ths.)35 190
Trades Count750
Dollar Volume310 726
Avg. Volume1 376 888
Avg. Weekly Volume763 879
Avg. Monthly Volume1 536 620
Avg. Quarterly Volume2 826 970

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

58%42%

Bearish Bullish

62%38%

Bearish Bullish

59%41%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingHold
3.00
Hold
3.00
Hold
3.00

There are no comments yet.

News

x